Arginine dependence of tumor cells: targeting a chink in cancer's armor

Area of Science:

• Biochemistry
• Cellular Physiology
• Oncology

Background:

• Arginine is a vital amino acid involved in numerous cellular metabolic and signaling pathways.
• Tumor cells often exhibit auxotrophy for arginine due to decreased expression of key metabolic enzymes.
• This arginine dependence presents a vulnerability exploitable for cancer treatment.

Purpose of the Study:

• To explore enzyme-mediated arginine depletion as a selective cancer therapy.
• To evaluate the potential of arginine-catabolizing enzymes in reducing tumor growth and enhancing chemotherapy.

Main Methods:

• Investigating the role of arginine auxotrophy in tumor cell physiology.
• Exploring the use of enzymes like arginase, arginine deiminase, and arginine decarboxylase for arginine depletion.
• Assessing the impact of these enzymes on tumor growth and susceptibility to anti-cancer therapeutics.

Main Results:

• Arginine deprivation leads to the demise of arginine-auxotrophic tumor cells.
• Arginine-catabolizing enzymes demonstrate potential in reducing tumor growth.
• These enzymes can enhance the effectiveness of concurrently administered anti-cancer therapies.

Conclusions:

• Enzyme-mediated arginine depletion is a viable strategy for selective tumor cell destruction.
• Arginase, arginine deiminase, and arginine decarboxylase are promising candidates for arginine deprivation therapy.
• Further clinical investigations are warranted to advance these enzymes as anti-cancer modalities.